Trial NCT02117479

View at ClinicalTrials.gov 
Org. Study IDs: INCB 18424-362

Last trial update was posted on 2019-03-26

MeSH Interventions

Capecitabine

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

The study was terminated early based on the results of the planned interim analysis.

Limitations And Caveats

The study was terminated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation at the recommendation of the Data Monitoring Committee.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID